NEULAND LABORATORIES
|
The Current P/S Ratio of NEULAND LABORATORIES is 11.94.
Share Price | ₹14,253.5 | Feb 07,2025 |
Market Cap | ₹18,244.5 Cr | |
Sales-TTM | ₹1,528.3 Cr | TTM-Consolidated Results |
Price/Sales | 11.94x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of NEULAND LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹18,244.5 Cr] as on Feb 07,2025
(/) Sales [ ₹1,528.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 11.94x ]
Thus, for NEULAND LABORATORIES , the investors are currently willing to pay '11.94 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of NEULAND LABORATORIES !
The chart below summarizes the trend in P/S Ratio of NEULAND LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of NEULAND LABORATORIES
PS Ratio Performance Analysis for NEULAND LABORATORIES
- NEULAND LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.37x.
- NEULAND LABORATORIES 's operated at median p/e ratio of 1.94x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NEULAND LABORATORIES 's p/e ratio peaked in Mar2024 at 5.17x.
- NEULAND LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 0.48x.
How does NEULAND LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
NEULAND LABORATORIES | 1,528.3 | 11.94 | 18,244.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 8.13 | 419,764.0 |
CIPLA LTD | 26,981.2 | 4.41 | 118,905.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.31 | 103,523.0 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.50 | 100,015.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 17.96 | 163,010.0 |
MANKIND PHARMA LTD | 11,641.0 | 8.93 | 103,904.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.76 | 110,313.0 |
LUPIN LTD | 21,431.3 | 4.68 | 100,405.0 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.28 | 69,214.1 |
ABBOTT INDIA LTD | 6,243.2 | 10.14 | 63,315.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NEULAND LABORATORIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.28x |
Max industry PS | 17.96x |
Median industry PS | 8.13x |
Average industry PS | 7.82x |
You may also like the below Video Courses